A randomized, multi center, double blinded, placebo-controlled,parallel-group, comparative clinical study to evaluate the immunomodulatory support and overall health benefits ofCUQ1720 and AK-CQAB-0520 among population with Allergic Rhinitis having significant nasal conjunction, sneezing andwheezing (upper respiratory infections).

Akay Natural Ingredients Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Subjects categorized as AR according to international guideline of American Academy of Allergy Asthma and Immunology
•2. History of allergic rhinitis (persistent or seasonal) symptoms for at least two consecutive years.
•3. No antibiotics use within 1 month prior to entering the study or during the study
•4. If female of childbearing age, willing to use an acceptable form of birth control measure, should be stable for past 3 months prior to baseline and throughout the Study
•5. Must be willing and able to give informed consent and comply with the study procedures

•1. Asthmatic subjects who required long term inhaled or systemic corticosteroids within the previous 30 days
•2. Subjects with nasal polyps and chronic respiratory tract infections
•3. Subjects having symptoms of viral infection, including COVID-19 infection
•4. Subjects with deteriorating health status at the time of enrolment, rapid weight loss, terminal disease, significant chronic disease (e.g., chronic diarrhoea, gastro-intestinal diseases, irritable bowel syndrome)
•5. History of Recent blood donation, Immunodeficiency disease (e.g., human immunodeficiency virus [HIV] infection)
•6. Concomitant medication/supplement which could affect the study
•7. Any contraindication to blood sampling
•8. Pregnant and lactating women
•9. Subjects allergic to herbal products, nuts or any component of the study product
•10. Currently participating or having participated in another clinical trial during the last 3 months prior to the beginning of this study
•11. Any additional condition(s) that in the Investigators opinion would warrant exclusion from the study or prevent the subject from completing the study.

发起方

Akay Natural Ingredients Pvt Ltd